Cynata Therapeutics set to join COVID challenge
MELBOURNE: Melbourne-based biotech Cynata Therapeutics is following in the footsteps of ASX-listed peer ... read more
Nearmap announces $90m raising but no dividends
SYDNEY: Aerial mapping provider Nearmap is taking advantage of a strong sharemarket to ... read more